For the NSCLC RET fusion positive cases, 0% (0/27) TMB-H were MSI-H; and for the other solid tumor RET fusion positive cases, 53.3% (24/45) TMB-H were also MSI-H. This evidence concerns the gene RET and non-small cell lung carcinoma.